当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2008年第25期
编号:11685668
二甲双胍治疗NASH的临床评价(2)
http://www.100md.com 2008年9月5日 郝美君 张祯祯 程丽英 黄爱龙
第1页

    参见附件(274KB,2页)。

     [参考文献]

    [1]Yoo J, Lee S, Kim K, et al. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children[J]. Diabetes Res Clin Pract,2008, 81(3):321-326.

    [2]Ciba I, Widhalm K. The association between nonalcoholic fatty liver disease and insulin resistance in 20 obese children and adolescents[J].Acta Paediatr,2007,96(1):109.

    [3]Roberts EA. Non-alcoholic steatohepatitis in children[J]. Clin Liver Dis,2007,11(1):155-172.

    [4]AJ Mc Cullough. Update on nonalcoholic fatty liver disease[J]. J Clin Gastroenterol,2002, 34(3):255–262.

    [5]RS Strauss, SE Barlow, WH Dietz. Prevalence of abnormal serum amin-otransferase values in overweight and obese adolescents[J]. J Pediatr,2002,136(6):727-733.

    [6]TS Burgert, SE Taksali, J Dziura, et al. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance,adiponectin and visceral fat[J]. J Clin Endocrinol Metab,2006, 91(11): 4287-4294.

    [7]鲜玉珍.二甲双胍治疗2型糖尿病临床分析[J].中国医药导报,2008,5(11):82,103.

    [8]柯涓.二甲双胍治疗空腹血糖受损的临床研究[J].中国医药导报,2006,3(17):34-35.

    (收稿日期:2008-07-08)

您现在查看是摘要介绍页,详见PDF附件(274KB,2页)